CRISIL reaffirms AA rating to Ipca Laboratories’ long term bank facilities

29 Oct 2012 Evaluate

Credit rating agency, CRISIL has reaffirmed AA rating to Ipca Laboratories’ long term bank facilities. The rating agency has also reaffirmed A1+ rating to the company’s Rs 1.5 billion short term debt while, the rating agency has reaffirmed AA/ stable rating to the company’s Rs 500 million Non Convertible Debentures (NCDs).

Further, CRISIL has assigned AA/stable rating to Rs 2,000 million NCDs of the company.

Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. It operates in 110 countries and its export accounts for 50% of the company’s income. Worldwide the company is one of the largest suppliers of APIs and intermediates. The company holds leadership position in Anti-malarial and Rheumatoid Arthritis area.

Ipca Laboratories Share Price

1590.55 17.35 (1.10%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.